Serina Therapeutics (SER) Non Operating Interest Expenses (2021 - 2026)
Serina Therapeutics' Non Operating Interest Expenses was $203,000 in Q2 2026, compared with $9,000 a year earlier.
Powered by 
Analysis
Serina Therapeutics (SER) Non Operating Interest Expenses (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Serina Therapeutics' Non Operating Interest Expenses was $416,000 through Jun 30, 2026, up 890.5% year-over-year; for FY2025, it came in at $213,000, down 59.5% from FY2024.
- Non Operating Interest Expenses has now declined for three consecutive years, with a four-year compound annual growth rate of -33.6% (FY2021 to FY2025).
- In earlier years, Non Operating Interest Expenses was $526,000 in FY2024 (-5.7%), $558,000 in FY2023 (-83.3%), $3.34 million in FY2022 (+204.0%) and $1.1 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Non Operating Interest Expenses since Q2 2024.
- The best year-over-year quarter for Non Operating Interest Expenses over five years was Q4 2022 (growth of 231.5%); the worst was Q2 2025 (a decline of 97.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Serina Therapeutics | 32.93 Mn | -7.81 Mn | - | 203,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 203,000.00 |
| Dec 31, 2025 | 198,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 307,000.00 |
| Mar 31, 2024 | 186,000.00 |
| Dec 31, 2023 | 176,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 108,000.00 |
| Mar 31, 2023 | 86,000.00 |
| Dec 31, 2022 | 978,000.00 |
| Sep 30, 2022 | 923,000.00 |
| Jun 30, 2022 | 863,000.00 |
| Mar 31, 2022 | 571,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Sep 30, 2021 | 285,000.00 |
API Access
Serina Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "SER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();